An expert review of the NSCLC landscape: EGFR in focus


Learning objectives:

After watching this broadcast, participants should be able to:

  • Evaluate the emerging treatment options available for EGFR-positive NSCLC
  • Describe how ongoing research into EGFR exon 20 insertions might drive clinical decision-making in patients with intrinsic resistance to EGFR TKIs



  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)



  • Joshua Bauml (USA)
  • Luis Paz-Ares (Spain)


This educational activity has been awarded 2 CPD points by CPDUK, a globally recognised provider of CPD.

More Info
62 Minutes
EM-51285 - Date of preparation: January 2021